Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,016 | -8,275 | -546,376 | -506,005 | -468,005 |
| Depreciation Amortization | 8,075 | 3,774 | 397,047 | 392,858 | 389,379 |
| Income taxes - deferred | N/A | N/A | -546 | -546 | -546 |
| Accounts receivable | 4,344 | 6,098 | -7,924 | -3,092 | -4,733 |
| Accounts payable and accrued liabilities | 1,156 | -4,322 | 2,482 | 761 | -505 |
| Other Working Capital | -2,822 | 3,172 | 4,442 | -3,051 | -6,258 |
| Other Operating Activity | -38,011 | -45,138 | 39,666 | 26,935 | 17,235 |
| Operating Cash Flow | $-80,274 | $-44,691 | $-111,209 | $-92,140 | $-73,433 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,484 | -4,198 | 123,162 | 96,272 | 77,456 |
| PPE Investments | 45,402 | 46,957 | -2,714 | -1,853 | -1,939 |
| Purchase Sale Intangibles | -7,056 | -5,000 | -5,000 | -5,000 | -5,000 |
| Other Investing Activity | -8,956 | -6,900 | -5,000 | -5,000 | -5,000 |
| Investing Cash Flow | $75,930 | $35,859 | $115,448 | $89,419 | $70,517 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,692 | 1,437 | 3,428 | 3,428 | 1,959 |
| Financing Cash Flow | $1,692 | $1,437 | $3,428 | $3,428 | $1,959 |
| Beginning Cash Position | 65,259 | 65,259 | 57,592 | 57,592 | 57,592 |
| End Cash Position | 62,607 | 57,864 | 65,259 | 58,299 | 56,635 |
| Net Cash Flow | $-2,652 | $-7,395 | $7,667 | $707 | $-957 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,274 | -44,691 | -111,209 | -92,140 | -73,433 |
| Capital Expenditure | -4,598 | -3,043 | -2,714 | -1,853 | -1,939 |
| Free Cash Flow | -84,872 | -47,734 | -113,923 | -93,993 | -75,372 |